Inflammatory Myofibroblastic Tumor of the Uterus
- 1 February 2015
- journal article
- review article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 39 (2) , 157-168
Abstract
Inflammatory myofibroblastic tumor is currently regarded as a neoplasm with intermediate biological potential and a wide anatomic distribution. Inflammatory myofibroblastic tumors of the female genital tract are rare, and to date reported cases behaved indolently. We describe, herein, 10 cases of uterine inflammatory myofibroblastic tumor, 3 of which had an aggressive clinical course. Subject age ranged from 29 to 73 years. Tumors were composed of spindle and epithelioid myofibroblastic cells admixed with lymphoplasmacytic infiltrates in a variably myxoid stroma. Two growth patterns, myxoid and fascicular (leiomyoma-like), were noted. All tumors were positive for ALK expression by immunohistochemistry, which was stronger in the myxoid areas. Smooth muscle marker and CD10 expression was variable in extent, but typically positive. Fluorescence in situ hybridization for ALK rearrangements was positive in both fascicular and myxoid areas in all 8 cases tested. Three subjects showed clinical evidence of tumor aggressiveness as defined by extrauterine spread, local recurrence, or distant metastasis. Aggressive tumors were larger, had a higher proportion of myxoid stroma, and higher mitotic activity than indolent tumors. Tumor cell necrosis was seen only in cases with adverse outcome. This is the first report to describe aggressive biological behavior in uterine inflammatory myofibroblastic tumor. This diagnosis is often underappreciated and merits inclusion in the differential diagnosis of myxoid mesenchymal lesions of the uterus, particularly because patients with an aggressive course may benefit from targeted therapy.Keywords
This publication has 30 references indexed in Scilit:
- Extrauterine inflammatory myofibroblastic tumor: A case reportGynecologic Oncology Case Reports, 2013
- Anaplastic lymphoma kinase-directed therapy in inflammatory myofibroblastic tumorsCurrent Opinion in Oncology, 2012
- Inflammatory pseudotumor of uterus: an unusual pelvic massEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2011
- Inflammatory myofibroblastic tumor of the uterus with prominent myxoid changePathology International, 2006
- Inflammatory myofibroblastic tumorsJournal of Surgical Oncology, 2006
- Inflammatory myofibroblastic tumor in children: clinical review with anaplastic lymphoma kinase, Epstein-Barr virus, and human herpesvirus 8 detection analysisJournal of Pediatric Surgery, 2005
- Inflammatory Myofibroblastic Tumor of the UterusAmerican Journal of Surgical Pathology, 2005
- Invasive inflammatory pseudotumor of uterine cervix: A case reportGynecologic Oncology, 2005
- Inflammatory myoblastic tumor of the uterus and interleukin-6American Journal of Obstetrics and Gynecology, 2003
- Inflammatory Pseudotumor of the UterusInternational Journal of Gynecological Pathology, 1987